Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Patient characteristics of opioid-related ambulance attendances for patients in justice settings in New South Wales, December 2020 – April 2023

From: Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System

Characteristics

Patients in prison

(n = 78)

Patients in police custody (n = 250)

All patients in justice settings

(n = 328)

Gender

Male

61 (78.2)

204 (81.6)

265 (80.8)

Female

17 (21.79)

46 (18.4)

63 (19.2)

Age group

18–24

11 (14.1)

20 (8.0)

31 (9.5)

25–34

34 (43.6)

107 (42.8)

141 (43.0)

35–44

24 (30.7)

81 (32.4)

105 (32.0)

45+

9 (11.5)

42 (16.8)

51 (15.6)

Opioid type a

Heroin

30 (38.5)

137 (54.8)

167 (50.9)

Prescription opioids

n < 5b

34 (13.6)

n≥32 (≥9.8)b

OAT

46 (59.0)

87 (34.8)

133 (40.6)

Nature of attendance a,

Consumption

39 (50.0)

170 (68.0)

206 (63.7)

Withdrawal

26 (33.3)

88 (35.2)

114 (34.8)

Other and unspecified harms c

14 (17.9)

5 (2.00)

19 (5.8)

Transported to hospital

70 (89.7)

174 (69.6)

244 (74.4)

  1. a Groups are not mutually exclusive, and a single attendance could involve more than one drug type or nature of attendance
  2. b Values obfuscated to protect patient anonymity
  3. c “Other and unspecified harms” includes attendances related to drug concealment, treatment-related incidents, and other unspecified harms